More than half of all patients with malignancy will have a pleural effusion at some time in their course. Recurrent malignant pleural effusions (MPE) impair function, worsen quality of life and, often herald a rapid demise for the patient. Once a patient develops MPE, only mechanical drainage relieves pulmonary compression and dyspne. Optimal treatment is still controversial. Between June 2001 and July 2003, our group treated 28 patients with outpatient insertion of a chronic indwelling pleural catheter (IPC), Pleurx (Pleurx TM , Surgimedics, Denver Biomaterials, Denver, CO USA). Primary malignancy of all 28 patients included 10 lung cancers, 7 mesotheliomas, 5 breast cancers, 3 colon cancers, 2 pancreas cancers, and one ovarian. Eligibiliy for IPC required prior throcentesis with histological confirmation of malignancy, and chest roentgenogram evidence of effusion. All patients treated had known prior malignancy and positive cytology for MPE in three patients, minor complications were observed. Major complications, as systemic or pleural infections, were not registered. The permanance mean time of IPC was 78 days. Median time of draining interval was 4.7 days with maximum amount of effusion drained being 1000 ml. Pleurodesis occurred in 13 of 28 (46.43%) patients with mean tinme of pleurodesis 48 days. IPC allows an ambulatory treatment with a safe and effective drainage of MPE and is an effective alternative treatment to the procedures currently in use. Still, randomized studies are necessary to compare this technique with the other most common procedures.